Tech Company Financing Transactions
Indigo Biosciences Funding Round
Indigo Biosciences closed a $500 thousand Series B funding round on 8/4/2016. Investors included private investors.
Transaction Overview
Company Name
Announced On
8/4/2016
Transaction Type
Venture Equity
Amount
$500,000
Round
Series B
Investors
Proceeds Purpose
INDIGO'S latest financing will be used to accelerate growth through new product development, continued development of a European strategy, and the expansion of domestic sales capabilities. This Series B financing is part of an overall goal to raise $1.5 million in investments.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3006 Research Dr. A1
State College, PA 16801
USA
State College, PA 16801
USA
Phone
Website
Email Address
Overview
INDIGO's mission is to provide innovative products and services to improve the speed, cost and risk in the drug discovery process.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Fred Marroni
Chief Scientific Officer
Jack Heuvel
Chief Technical Officer
Bruce Sherf
Browse more venture capital transactions:
Prev: 8/4/2016: Velostrata venture capital transaction
Next: 8/4/2016: Ceros venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs